Dynamic Effects of Different Dietary Interventions on Visceral Fat and Biochemical Markers
A Randomized Controlled Trial on the Dynamic Effects of Different Dietary Interventions on Visceral Fat and Other Biochemical Markers
1 other identifier
interventional
84
1 country
1
Brief Summary
This randomized clinical trial aims to evaluate the dynamic effects of various dietary interventions on visceral fat and biochemical markers among healthy adults. Participants aged 18-35 years with a normal body mass index (BMI 18.5-23.9) will be recruited from the community. Exclusion criteria include metabolic diseases, unstable weight, medication use, or pregnancy. Participants will be randomly assigned to one of seven groups: 1) balanced diet (100% energy), 2) time-restricted eating (16+8, 100% energy), 3) time-restricted eating (16+8, 75% energy), 4) alternate-day fasting (75% energy), 5) 5+2 fasting (75% energy), 6) low-calorie diet (75% energy), and 7) very low-calorie diet (45% energy). The intervention consists of a 1-week baseline phase, a 4-week dietary intervention phase, and a 28-week recovery phase. Primary outcomes include changes in visceral fat area, while secondary outcomes include body composition, cardiovascular health indicators (e.g., blood pressure, cholesterol), inflammation markers, and liver/kidney function. Biological samples (blood, urine, and feces) will be collected at multiple time points to facilitate multi-omics analyses, including proteomics, metabolomics, metagenomics, and DNA methylation. The study aims to compare the short-term effects of different dietary interventions and explore underlying biological mechanisms. Findings will provide evidence for public health policies and dietary guidelines related to weight management and metabolic health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 25, 2024
CompletedFirst Submitted
Initial submission to the registry
December 18, 2024
CompletedFirst Posted
Study publicly available on registry
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2025
CompletedNovember 28, 2025
November 1, 2025
10 months
December 18, 2024
November 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Visceral Fat Area over the Course of the Dietary Intervention
Visceral fat area will be measured using the InBody770 bioelectrical impedance analysis (BIA) device.
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32
Secondary Outcomes (31)
Change in Body Weight over the Course of the Dietary Intervention
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32
Change in Waist Circumference over the Course of the Dietary Intervention
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32
Change in Hip Circumference over the Course of the Dietary Intervention
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32
Body height at Baseline
Baseline only
Change in Body Mass Index (BMI) over the Course of the Dietary Intervention
Baseline, Week 1, Week 2, Week 3, Week 4, Week 5, Week 8, and Week 32
- +26 more secondary outcomes
Study Arms (7)
Balanced diet group
EXPERIMENTALDaily intake of 100% energy requirements, adjusted individually based on each participant's basal metabolic rate (BMR) and activity level.
16+8 time-restricted eating group (100% energy)
EXPERIMENTALParticipants will consume 100% energy within an 8-hour eating window and fast for the remaining 16 hours.
16+8 time-restricted eating group (75% energy)
EXPERIMENTALParticipants will consume 75% of their energy requirements within the 8-hour eating window.
Alternate-day fasting group (75% energy)
EXPERIMENTALParticipants alternate between "feeding days" (125% energy requirements) and "fasting days" (25% energy requirements).
5+2 intermittent fasting group (75% energy)
EXPERIMENTALParticipants consume 95% energy requirements for 5 consecutive days and 25% energy requirements for 2 fasting days.
Low-calorie diet group (75% energy)
EXPERIMENTALParticipants will reduce daily caloric intake to 75% of energy requirements, consumed evenly across three meals.
Very low-calorie diet group (45% energy)
EXPERIMENTALParticipants will reduce daily caloric intake to 45% of energy requirements (\~800 kcal/day)
Interventions
Daily intake of 100% energy requirements, adjusted individually based on each participant's basal metabolic rate (BMR) and activity level.
Participants will consume 100% energy within an 8-hour eating window and fast for the remaining 16 hours.
Participants will consume 75% of their energy requirements within the 8-hour eating window.
Participants alternate between "feeding days" (125% energy requirements) and "fasting days" (25% energy requirements).
Participants consume 95% energy requirements for 5 consecutive days and 25% energy requirements for 2 fasting days.
Participants will reduce daily caloric intake to 75% of energy requirements, consumed evenly across three meals.
Participants will reduce daily caloric intake to 45% of energy requirements (\~800 kcal/day)
Eligibility Criteria
You may qualify if:
- Participants aged 18-35 years.
- BMI between 18.5 and 23.9.
- Willing to voluntarily sign the informed consent form and comply with group assignments and intervention protocols.
You may not qualify if:
- Diagnosed with metabolic diseases such as hypertension, diabetes, or dyslipidemia.
- Diagnosed with uncontrolled psychiatric disorders.
- Diagnosed with severe underlying diseases, such as renal failure, heart failure, or cancer.
- Currently taking medications that may affect study outcomes (e.g., antihypertensive, antidiabetic, or lipid-lowering drugs).
- Women in the perimenopausal stage or with irregular menstrual cycles.
- Pregnant women.
- Current smokers.
- Unstable weight within the past three months (fluctuations exceeding 4 kg).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
School of Public Health, Shanghai Jiao Tong University, Shanghai, China
Shanghai, Shanghai Municipality, 200025, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Wang, PhD
School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Professor, and Doctor
Study Record Dates
First Submitted
December 18, 2024
First Posted
December 31, 2024
Study Start
August 25, 2024
Primary Completion
June 9, 2025
Study Completion
June 9, 2025
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
We acknowledge the importance of data sharing for scientific advancement; however, due to the absence of a predefined data sharing mechanism in our study design and the need to prioritize participant confidentiality, we currently do not have a plan to share individual participant data (IPD). We remain open to exploring future opportunities to share aggregate data or collaborate with interested researchers within an ethically appropriate framework.